hydrazine has been researched along with Multiple Sclerosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gao, H; Huang, L; Linnik, MD; Miller, A; O'rourke, A; Podar, EM; Salter-Cid, L; Wang, EY; Zhang, J; Zhao, J | 1 |
Gao, HF; Huang, L; Jones, DS; Linnik, MD; Miller, A; O'Rourke, AM; Podar, E; Salter-Cid, L; Wang, EY | 1 |
2 other study(ies) available for hydrazine and Multiple Sclerosis
Article | Year |
---|---|
Design, synthesis, and biological evaluation of semicarbazide-sensitive amine oxidase (SSAO) inhibitors with anti-inflammatory activity.
Topics: Acute Disease; Amine Oxidase (Copper-Containing); Animals; Anti-Inflammatory Agents, Non-Steroidal; Encephalomyelitis, Autoimmune, Experimental; Female; Hydrazines; In Vitro Techniques; Lung; Mice; Mice, Inbred C57BL; Multiple Sclerosis; Rats; Structure-Activity Relationship | 2006 |
Benefit of inhibiting SSAO in relapsing experimental autoimmune encephalomyelitis.
Topics: Amine Oxidase (Copper-Containing); Animals; Cell Adhesion; Cell Adhesion Molecules; Chemotaxis, Leukocyte; Disease Progression; Encephalomyelitis, Autoimmune, Experimental; Enzyme Inhibitors; Female; Hydrazines; Immunosuppression Therapy; Mice; Multiple Sclerosis; Secondary Prevention; Treatment Outcome | 2007 |